The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results from phase II study of combination treatment with HF10, a replication-competent HSV-1 oncolytic virus, and ipilimumab in patients with stage IIIb, IIIc, or IV unresectable or metastatic melanoma.
 
Robert Hans Ingemar Andtbacka
Honoraria - Amgen; Merck
Consulting or Advisory Role - Amgen; Merck
Research Funding - Amgen (Inst)
 
Merrick I. Ross
Honoraria - Amgen; Caladrius Biosciences; GlaxoSmithKline; Merck
Consulting or Advisory Role - Amgen; GlaxoSmithKline; Merck
Speakers' Bureau - Merck
Research Funding - Amgen (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Provectus (Inst)
Travel, Accommodations, Expenses - Amgen; Caladrius Biosciences; GlaxoSmithKline; Merck; Provectus
 
Sanjiv S. Agarwala
No Relationships to Disclose
 
Matthew H. Taylor
Honoraria - Eisai
Consulting or Advisory Role - Eisai; Onyx
 
John T. Vetto
Employment - Genentech/Roche (I)
Stock and Other Ownership Interests - Genentech/Roche (I)
Honoraria - Castle Biosciences (I)
 
Rogerio Izar Neves
Consulting or Advisory Role - Amgen; Roche
Research Funding - Novartis; Takara Bio (Inst)
 
Adil Daud
Stock and Other Ownership Interests - Oncosec
Consulting or Advisory Role - GlaxoSmithKline; Merck; Oncosec
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck/Schering Plough (Inst); oncosec (Inst); Pfizer (Inst)
 
Hung T. Khong
Stock and Other Ownership Interests - Exelixis
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst)
 
Richard S. Ungerleider
No Relationships to Disclose
 
Aislyn Boran
Stock and Other Ownership Interests - Amicus Therapeutics (I); Sarepta Therapeutics (I); TetraLogic Pharmaceuticals
 
Maki Tanaka
Employment - Takara Bio
 
Kenneth F. Grossmann
Consulting or Advisory Role - Bristol-Myers Squibb (I); Castle Biosciences; Roche/Genentech